Imaging and Biomarker in Alzheimer’s Disease
Dr. Philip Scheltens reviews using biomarkers for early diagnosis of Alzheimer’s disease (AD) and the benefits of early diagnosis.
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
Dr. Philip Scheltens reviews using biomarkers for early diagnosis of Alzheimer’s disease (AD) and the benefits of early diagnosis.